PER
Click for more information
34.1% 8.9¢ percheron therapeutics limited

Chart, page-3377

  1. itsagas
    13,608 Posts.
    lightbulb Created with Sketch. 1455
    clock Created with Sketch.
    01/04/21
    11:39
    Post #: 52201084
    UBoy: if we get European and FDA approval for Atl1102 for DMD and Inflammation .... With $130 billion market per annum ... Yes !! CSL share price achievable$$
    ANP Price at posting: 22.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
NEWS Sierra Nevada raises $2M for silver exploration at Blackhawk
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.9¢ 		Change
-0.046(34.1%) 		Mkt cap ! $80.23M
Open High Low Value Volume
8.7¢ 9.0¢ 8.6¢ $2.082M 23.82M

Buyers (Bids)

No. Vol. Price($)
5 250808 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 312804 3
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.